The impact of PET/CT in the management of recurrent ovarian cancer

Gynecologic Oncology
Bryony SimcockRodney J Hicks

Abstract

To evaluate the impact of PET/CT on the restaging and management of recurrent ovarian cancer. From January 2002 to July 2003, all women undergoing either surveillance or investigation of possible recurrent ovarian cancer at the Centre for Molecular Imaging, The Peter MacCallum Cancer Centre, were invited to take part in a prospective evaluation of the clinical impact of PET/CT. Fifty-six women having 66 scans were available for analysis. All patients had at least 12months follow-up after the PET/CT unless they died before that time. Apart from one equivocal scan, all scans performed in women with a CA125 higher than 35IU/ml had a positive PET/CT. PET/CT altered the known disease distribution in 40 scans (64%). Overall, PET/CT showed less disease in six scans (9%) and more disease in 34 scans (52%). Regardless of the value of CA125, PET/CT identified a sub group of women with apparently localized disease or no definite evidence of disease. This group showed improved survival compared with women shown to have systemic disease. PET/CT resulted in a major change of management plan in 34 patients (58%). PET/CT modifies the assessment of the distribution of recurrent ovarian cancer and alters patient management in a substantial propo...Continue Reading

References

Apr 12, 1990·The New England Journal of Medicine·J B Friedman, N S Weiss
Apr 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G J RustinH E Lambert
May 25, 2001·AJR. American Journal of Roentgenology·Y NakamotoJ Konishi
Apr 26, 2002·Gynecologic Oncology·Maurie Markman
Jul 20, 2002·AJR. American Journal of Roentgenology·Song-Mee ChoJoon Mo Lee
Jan 1, 1997·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A GadducciR Cristofani
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Perry W GrigsbyImran Zoberi

❮ Previous
Next ❯

Citations

Nov 14, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Yasuhiko EbinaNoriaki Sakuragi
May 23, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Daniela Fischerova, Andrea Burgetova
May 28, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Antonia Carla TestaVittoria Rufini
Sep 16, 2008·Abdominal Imaging·Anna Maria De GaetanoLorenzo Bonomo
Mar 19, 2011·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Hongju SonLale Kostakoglu
Nov 2, 2014·Seminars in Nuclear Medicine·Paul GrantHeather A Jacene
May 22, 2010·AJR. American Journal of Roentgenology·Priyanka PrakashMichael A Blake
Mar 24, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Ahmet BiliciMahmut Gumus
Nov 30, 2010·Annals of Nuclear Medicine·Kazuhiro KitajimaKazuro Sugimura
Oct 21, 2009·Current Oncology Reports·Rebecca A Brooks, Matthew A Powell
Nov 12, 2013·Radiologic Clinics of North America·Chitra ViswanathanRaghunandan Vikram
Aug 29, 2012·Magnetic Resonance Imaging·Hye Jeong LeeRonald R Price
Jan 17, 2012·Critical Reviews in Oncology/hematology·Maurizia Dalla PalmaVittorina Zagonel
Aug 10, 2010·Gynecologic Oncology·John O SchorgeThomas J Herzog
Dec 20, 2008·Revista española de medicina nuclear·J I Cuenca CuencaR Fernández López
Apr 22, 2008·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Yorito YamamotoTakao Fukaya
Aug 4, 2009·Seminars in Nuclear Medicine·Dominique DelbekeRichard L Wahl
Oct 12, 2007·Expert Opinion on Pharmacotherapy·Susan C Modesitt, Amir A Jazaeri
Apr 4, 2012·Molecular Oncology·Moritz F KircherSteven M Larson
Nov 16, 2010·Gynecologic Oncology·Garo Z HarmandayanFrank E Johnson
Jan 31, 2009·Critical Reviews in Oncology/hematology·Angiolo Gadducci, Stefania Cosio
Mar 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerR Edward Coleman
Dec 25, 2008·Expert Review of Anticancer Therapy·Sandip BasuAbass Alavi
Nov 22, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Seung-Hyuk ShimJoo-Hyun Nam
Jul 25, 2009·Obstetrical & Gynecological Survey·Vanessa N HarryDavid E Parkin
Aug 14, 2008·Australasian Physical & Engineering Sciences in Medicine·Z BradyJ V Trapp
Apr 14, 2010·Nature Reviews. Clinical Oncology·Stavroula KyriaziNandita M deSouza
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Evis SalaUNKNOWN Gynaecological Cancer InterGroup
May 2, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angiolo GadducciPaolo Zola
Feb 16, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hye Jeong LeeRonald R Price
Aug 24, 2017·The British Journal of Radiology·Priya Narayanan, Anju Sahdev
Feb 20, 2013·Oncology Letters·Sanja DragosavacGustavo DE Souza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.